Take a look at some of Monday's morning movers:
SanDisk - Goldman Sachs has upgraded the flash memory product maker to "buy" from "neutral," because of factors like an improved supply/demand balance.
Netflix - The stock has been upgraded to "neutral" from "sell" at Janney Capital. The firm believes the risk/reward ratio is more balanced after a recent selloff and downward revisions in earnings estimates by a number of Wall Street analysts.
Boeing - Oppenheimer has upgraded the jet maker's stock to "outperform" from "perform," saying investors are ignoring the growing momentum of the 787 Dreamliner aircraft.
Watson Pharmaceuticals - The U.S. Food and Drug Administration has approved its generic version of hyperactivity drug Adderall XR. Adderall’s maker, Britain’s Shire, had sought to block the generic version from coming to market.
Abbott Laboratories - Belgian drugmaker Ablynx said its arthritis treatment shows a benefit over Abbott’s best-selling Humira.
Research In Motion - RIM is considering separating out its handset manufacturing business from its messaging network. That’s according to London’s Sunday Times. The paper said Amazon.com and Facebook could be potential buyers.Page 1 of 3 | Next Page